• Find people
• Intranet

Myogenesis, Inflammation & Muscle Function Joaquim Gea

Publications 2024 (5)

• Josa-Culleré A, Basagaña X, Koch S, Arbillaga A, Balcells E, Bosch de Basea M, Celorrio N, Foraster M, Rodríguez-Roisín R, Marin A, Peralta GP, Rodríguez DA, Simonet P, Torán P, Vall-Casas P, Garcia-Aymerich J^*. Short-term effects of air pollution and weather on physical activity in patients with chronic obstructive pulmonary disease (COPD). Environ Res 2024; 247: (en Premsa).
• Caguana OA, Khilzi K, Piccari L, Rodríguez-Sevilla JJ, Badenes D, González-Garcia J, Chalela R, Arita M, Rodó A, Herranz A, Admetllo M, Villar-García J, Molina L, Zuccarino F, Gea J, Balcells E, Rodríguez DA^*. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration 2024; 103(2): 79-87.
• Piccari L, Wort SJ^*. Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?. Thorax 2024; 79(4): 295-296.
• Shlobin OA^*, Shen E, Wort SJ, Piccari L, Scandurra JA, Hassoun PM, Nikkho SM, Nathan SD. Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulm Circ . 2024; 14(1): e12310 (Acceptat).
• Margaritopoulos GA^*, Proklou A, Trachalaki A, Badenes D, Kokosi M, Kouranos V, Chua F, George P, Renzoni EA, Devaraj A, Desai S, Nicholson AG, Antoniou KM, Wells AU. Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality. ERJ Open Res 2024; 10(1): 00740-2023 (Acceptat).